Next Gen Sequencing (NGS) Market | USD 17.15 Billion 2024 | CAGR Of 18.6%
Added: (Fri Jan 11 2019)
Pressbox (Press Release) -
A Research Report On Next Generation Sequencing Market Comprising Of Markets Current And Future Trends
The Next Gen Sequencing (NGS) Market Is Projected To Reach USD 17.15 Billion By 2024 From USD 5.13 Billion In 2017, At A CAGR Of 18.6% During The Forecast Period
Changing aspects of Next generation sequencing market
The global next generation sequencing market is growing due to following factors such as-
Increase in gene mapping activities
Affordable cost of sequencing and technological development in personalized medicine
Adding to this, rise in R & D activities by market players, drug discovery applications
However, dearth for skilled professionals, storage and management of patient data and ethical and legal issues related to the practices will hamper the next generation sequencing market.
Request Sample Report : https://bit.ly/2KXG7GN
Regional analysis:
North America is anticipated to hold the largest share due to increased R & D activities for proteomic and genomic sequence, rise in adoption of next generation sequence techniques is helping to grow the market. Moreover, countries such as U.S., U.K. and Germany which are offering courses related to molecular biology which is also help to grow the next generation sequence market.
Asia-Pacific is growing at faster rate in the global next generation sequencing market due to factors such as rising awareness about medical opportunities, increasing government initiatives and rise in partnerships and agreements among market players.
Market summary:
Local and international market players are actively involved in research, development and marketing of next generation sequencing market. Growing acquisitions, partnerships, collaborations and mergers are adopted by research laboratories and academic institutes and innovative products by market players are fueling the market of next-generation sequencing market. In addition to this, scientists and drug developers are working towards development of personalized medicine in order to boost the next generation sequencing market.
Notable market development:
Together with Amgen, Illuminas next-generation sequencing cancer companion diagnostic test kit was FDA approved in 2017.
Some of the players in global next-generation sequencing market are
Agilent Technologies, Inc. (U.S.)
Illumina, Inc. (U.S.)
Pacific Biosciences (Danaher Corporation) (U.S.)
Thermo Fisher Scientific Inc. (U.S.)
Qiagen N. V. (Germany)
Beijing Genomics Institute (China)
PerkinElmer, Inc (U.S.)
F. Hoffmann La Roche AG (Switzerland)
Genomatix GmbH (Germany)
Oxford Nanopore Technologies (U.K.)
Eurofins Scientific (U.S.)
The global next generation sequencing market is divided into following categories-
By product and service type
Pre-sequencing products and services market
o DNA fragmentation, size selection, A-tailing, and end repair
o Library preparation and target enrichment
o Quality control
Sequencing services market
o Targeted sequencing/gene panels
o RNA-Seq
o De Novo sequencing
o Exome sequencing
o Chip-Seq
o Whole-genome sequencing
o Methyl-Seq
o others
Next-generationn sequencing, data analysis, storage, and management (Bioinformatics) market
o NGS data analysis software & workbenches
o NGS data analysis services
o NGS storage management and cloud computing solutions
By technology
Ion semiconductor sequencing
Sequencing by the synthesis (SBS)
Nanopore sequencing
Single-molecule real-time (SMRT) sequencing
By application
Drug discovery
Diagnostics
Agriculture and animal research
Biomarker discovery
Precision medicine
Other applications
By end-users
Biotechnology and Pharmaceutical Companies
Research Centres
Hospitals & Clinics
Others
By geographical regions
North America
Latin America
Europe
Asia-Pacific
The Middle East & Africa
For More Information: https://www.precisionbusinessinsights.com/market-reports/global-next-generation-sequencing-market/